(Q44183540)

30 November 2017

Structure-activity relationships of some 3-substituted-4-hydroxycoumarins as HIV-1 protease inhibitors (English)

1 reference

30 November 2017

Serge Kirkiacharian

1

1 reference

30 November 2017

Duong Thanh Thuy

2

1 reference

30 November 2017

Sames Sicsic

3

1 reference

30 November 2017

Robert Bakhchinian

4

1 reference

30 November 2017

Raffi Kurkjian

5

1 reference

30 November 2017

Thierry Tonnaire

6

1 reference

30 November 2017

1 September 2002

1 reference

30 November 2017

1 reference

30 November 2017

57

1 reference

30 November 2017

9

1 reference

30 November 2017

703-708

1 reference

The daunting challenge of keeping HIV suppressed

30 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2802%2901264-8

Characterization of human immunodeficiency virus type 1 mutants with decreased sensitivity to proteinase inhibitor Ro 31-8959.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2802%2901264-8

In vivo emergence of HIV-1 variants resistant to multiple protease inhibitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2802%2901264-8

Development of drug resistance to HIV-1 protease inhibitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2802%2901264-8

Structure-based design of HIV protease inhibitors: 4-hydroxycoumarins and 4-hydroxy-2-pyrones as non-peptidic inhibitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2802%2901264-8

Competitive inhibition of HIV-1 protease by warfarin derivatives

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2802%2901264-8

Structure-based design of sulfonamide-substituted non-peptidic HIV protease inhibitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2802%2901264-8

Competitive inhibition of HIV-1 protease by 4-hydroxy-benzopyran-2-ones and by 4-hydroxy-6-phenylpyran-2-ones

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2802%2901264-8

Structure-based design of HIV protease inhibitors: 5,6-dihydro-4-hydroxy-2-pyrones as effective, nonpeptidic inhibitors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2802%2901264-8

Structure-based design of novel HIV protease inhibitors: sulfonamide-containing 4-hydroxycoumarins and 4-hydroxy-2-pyrones as potent non-peptidic inhibitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2802%2901264-8

Structure-based design of HIV protease inhibitors: sulfonamide-containing 5,6-dihydro-4-hydroxy-2-pyrones as non-peptidic inhibitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2802%2901264-8

Three-dimensional structure of aspartyl protease from human immunodeficiency virus HIV-1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2802%2901264-8

Conserved folding in retroviral proteases: crystal structure of a synthetic HIV-1 protease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2802%2901264-8

Structure-based design of novel HIV protease inhibitors: carboxamide-containing 4-hydroxycoumarins and 4-hydroxy-2-pyrones as potent nonpeptidic inhibitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2802%2901264-8

A novel nonpeptide HIV-1 protease inhibitor: elucidation of the binding mode and its application in the design of related analogs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2802%2901264-8

Structure-based inhibitors of HIV-1 protease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2802%2901264-8

10.1016/S0014-827X(02)01264-8

7 January 2021

Identifiers

DOI

1 reference

30 November 2017

1 reference